Great Lakes Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-24,111
Closed -$3.09M 566
2019
Q2
$3.09M Buy
+24,111
New +$3.35M 0.07% 285
2018
Q4
Sell
-36,317
Closed -$8.05M 598
2018
Q3
$8.05M Sell
36,317
-2,743
-7% -$556K 0.18% 130
2018
Q2
$6.26M Buy
39,060
+518
+1% +$66.2K 0.15% 159
2018
Q1
$3.6M Buy
+38,542
New +$2.88M 0.09% 224
2014
Q1
Sell
-24,331
Closed -$636K 381
2013
Q4
$636K Buy
24,331
+9,738
+67% +$250K 0.03% 207
2013
Q3
$392K Sell
14,593
-188
-1% -$5.03K 0.02% 275
2013
Q2
$381K Buy
+14,781
New +$388K 0.02% 272

Other funds holding MED

Great Lakes Advisors's MED Position: Q3 2019 in Review

Great Lakes Advisors sold out of Medifast (MED) in Q3 2019, closing a stake of 24,111 shares — an estimated $3.09M sold.

Great Lakes Advisors first reported a position in MED in Q2 2013 and held it in 7 quarters. The position peaked at $8.05M in Q3 2018. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Great Lakes Advisors reported no remaining Medifast position as of Q3 2019 after selling out during the quarter.
  • Great Lakes Advisors sold 24,111 Medifast shares in Q3 2019, an estimated $3.09M.
  • Great Lakes Advisors first reported a position in Medifast in Q2 2013 and held it in 7 quarters.
  • Great Lakes Advisors's Medifast position peaked at $8.05M in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Great Lakes Advisors's 13F filing for Q3 2019, filed 6 Nov 2019.